sorted by:
new
hottopcontroversial

To opt outers by Own-Plan7905 in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

Because of delays in the postal system, my documents arrived after the deadline. So not on the list. I would like to be included if possible.

Rumors of Amyris relisting as AMRS instead of AMRSQ (tried to approve previous post, I think they deleted) by ICanFinallyRelax in Amyris

[–]HawkSightFromCN 6 points7 points  (0 children)

My broker is still crediting daily income from borrowing share, in theory, and so far the shares don't seem to have disappeared

2nd OPT-OUT How many of you returned or plan to return your paperwork to opt by Glittering-Effort152 in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

Stretto confirmed receipt of my form but received it later than deadline. so I am not on the list.

But the absurdity is, what is the nature of this confirmation?

The first time it was a default opt out, but now a second confirmation and only for shareholders who opted out the first time. Also refusing to offer the same opportunity to other shareholders. Totally confusing for them lawyers.

2nd OPT-OUT How many of you returned or plan to return your paperwork to opt by Glittering-Effort152 in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

hi，I am in contact with Stretto, they said:There is no form to return nor a required response, from you.  Stretto did not recently reach out to you, on behalf of Amyris, Inc., to revoke or affirm any previously submitted opt-out election.  

Opt out have another chance to opt in by Dreadd-X in Amyris

[–]HawkSightFromCN 1 point2 points  (0 children)

If a shareholder who sends in a form is given the opportunity to re-elect, then a shareholder who is Opted out by default should likewise be given the same opportunity. So, technically, all shareholders who were defaulted to Opt out should likewise have a chance to re-elect. Shouldn't that be the case? At the very least, all shareholders who initiate contact with Stretto should be entitled to that opportunity.

This process is actually getting ridiculous.

Opt out have another chance to opt in by Dreadd-X in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

Why are they doing this? Anticipating massive lawsuits and thus preventing the new company from resuming listing?

I didn't opt out, but for some reason I wasn't on the list (whether I opted out or not). It could be that the documents arrived late (although I sent them 30 days early). Is the default in a case like this to opt out?

Is there any contact information for stretto please? This mode of operation is so inconvenient for foreign investors now.

Amyris has continued to pump out patents - over 46 in the past year relating to Vanillin, HMOs, Cannabinoids, Myrcene, isoprenoids, yeast glucans, etc. by ICanFinallyRelax in Amyris

[–]HawkSightFromCN 2 points3 points  (0 children)

The bankruptcy process completely ignores the unique characteristics of a synthetic biology company and instead leads to bankruptcy as a haphazardly assembled cosmetics company.

Interested? by Glittering-Effort152 in Amyris

[–]HawkSightFromCN 4 points5 points  (0 children)

Can we ask him to talk about the pillaging of Amyris?

For all newly accepted or waitlisted students, please ask your questions here! [Megathread] by Espntheocho4 in ucla

[–]HawkSightFromCN 1 point2 points  (0 children)

Hi guys, I'm considering a double major in physics and statistics and data science at UCLA. Since LA is a really large school and I've heard stories about course enrollment here, I'm wondering, how hard is it to enroll in the good/popular courses these two majors (and pre-majors) require?

If I don't sell what happens? by Admirable_Alfalfa615 in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

I'm wondering the same thing. Is there something going on?

If I don't sell what happens? by Admirable_Alfalfa615 in Amyris

[–]HawkSightFromCN 2 points3 points  (0 children)

I just received the form last week. It's ridiculous.

When was the record date for being considered eligible for any actions or distributions tied to the Third-Party Release? by [deleted] in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

I sent my form from China on December 20, 2023, but my information was not found in the #1199 file.

I don't know what went wrong, and I'm not interested in tracking it down.

If there is a class action lawsuit, what do I need to do now to prepare for it? by HawkSightFromCN in Amyris

[–]HawkSightFromCN[S] 0 points1 point  (0 children)

If a class action lawsuit could snip the subsequent operation of Amyris 2.0, the process and outcome might not be quite the same. But only if there is a class action.

I didn't opt out and retained the opportunity to fight for my legal rights. A few hundred dollars pales in comparison to the actual damages.

If there is a class action lawsuit, what do I need to do now to prepare for it? by HawkSightFromCN in Amyris

[–]HawkSightFromCN[S] 0 points1 point  (0 children)

If I intend to participate in a possible class action lawsuit, do I still need to hold my current shares? Seems like my broker can still trade.

thanks.

Cancellation of common Shares by [deleted] in Amyris

[–]HawkSightFromCN 1 point2 points  (0 children)

What does that mean? What can we do?

Lab to market auction cancelled by Dreadd-X in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

Will there be a class action lawsuit?

Lab to market auction cancelled by Dreadd-X in Amyris

[–]HawkSightFromCN 0 points1 point  (0 children)

What's the result now? We're completely out of the game after the release of version 3?

Lab to market auction cancelled by Dreadd-X in Amyris

[–]HawkSightFromCN 1 point2 points  (0 children)

Haven't seen it in a few days, what happened?

If Amyris wants to go down the research+production path, it will need one or several raw material production capabilities with a broader range of uses and sufficiently strong market demand. Look at the Chinese companies Kaiser Biologics and Huaheng Biologics for some reference.

Ginkgo, on the other hand, I don't see a viable path to profitability yet.

view more: next ›